Keywords: bioalliance, completes, phase, iii, loramyc, trial, france

BioAlliance completes US Phase III Loramyc trial

Article | 26 November 2007

Print This

France's BioAlliance Pharma SA has completed patient enrollment in a pivotal Phase III trial performed with a view to registering ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in